Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders Nia JulianOctober 23, 2019
Arcellx Raises $85 Million in a Series B Financing to Advance its Intelligent Cell Therapy Platform Nia JulianOctober 3, 2019
G1 Therapeutics Presents First Clinical Data on Oral SERD G1T48 Demonstrating Safety and Tolerability in Patients with Advanced Breast Cancer at ESMO 2019 Nia JulianSeptember 29, 2019
